EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
Discover how to turn your visits to the doctor into passive income by becoming a stakeholder in their business. Click here to ...
2hon MSN
The banks have been quietly celebrating. The oil and gas giants are preparing fresh investment plans. The tech giants have ...
AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...
Manila Water Foundation Joins Erceflora Probiotics and Save the Children Philippines to Expand Hygiene and Water Access for ...
Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...
The company also finalized a collaboration agreement with Sanofi and settled previous repurchase obligations, streamlining its operations. Despite a net loss from continuing operations of $38.9 ...
The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK ...
Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.
(Reuters) - Europe's STOXX 600 opened lower on Friday, dragged by technology and healthcare stocks, keeping the index on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback